Evidence map›Paper›PMID 28306742›Full record

ArticlePLoS pathogens2017

HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.

Nagayasu Egawa, Qian Wang, Heather M Griffin, Isao Murakami, Deborah Jackson, Radma Mahmood, John Doorbar

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Alternative splicing in the genome of HPV and its regulation.Frontiers in cellular and infection microbiology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nagayasu EgawaDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Qian WangFrancis Crick Institute, Mill Hill Laboratory, The Ridgeway, Mill Hill, London, United Kingdom.
Heather M GriffinDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Isao MurakamiDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-7189-3315
Deborah JacksonFrancis Crick Institute, Mill Hill Laboratory, The Ridgeway, Mill Hill, London, United Kingdom.
Radma MahmoodFrancis Crick Institute, Mill Hill Laboratory, The Ridgeway, Mill Hill, London, United Kingdom.
John DoorbarDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-4027-102X
University of Cambridge · GBThe Francis Crick Institute · GB

Funding

Medical Research Council MC_PC_13050
6 · The paper itself

Abstract

To clarify E1^E4's role during high-risk HPV infection, the E4 proteins of HPV16 and 18 were compared side by side using an isogenic keratinocyte differentiation model. While no effect on cell proliferation or viral genome copy number was observed during the early phase of either virus life cycle, time-course experiments showed that viral genome amplification and L1 expression were differently affected upon differentiation, with HPV16 showing a much clearer E4 dependency. Although E4 loss never completely abolished genome amplification, its more obvious contribution in HPV16 focused our efforts on 16E4. As previously suggested, in the context of the virus life cycle, 16E4s G2-arrest capability was found to contribute to both genome amplification success and L1 accumulation. Loss of 16E4 also lead to a reduced maintenance of ERK, JNK and p38MAPK activity throughout the genome amplifying cell layers, with 16E4 (but not 18E4) co-localizing precisely with activated cytoplasmic JNK in both wild type raft tissue, and HPV16-induced patient biopsy tissue. When 16E1 was co-expressed with E4, as occurs during genome amplification in vivo, the E1 replication helicase accumulated preferentially in the nucleus, and in transient replication assays, E4 stimulated viral genome amplification. Interestingly, a 16E1 mutant deficient in its regulatory phosphorylation sites no longer accumulated in the nucleus following E4 co-expression. E4-mediated stabilisation of 16E2 was also apparent, with E2 levels declining in organotypic raft culture when 16E4 was absent. These results suggest that 16E4-mediated enhancement of genome amplification involves its cell cycle inhibition and cellular kinase activation functions, with E4 modifying the activity and function of viral replication proteins including E1. These activities of 16E4, and the different kinase patterns seen here with HPV18, 31 and 45, may reflect natural differences in the biology and tropisms of these viruses, as well as differences in E4 function.

Indexed as

Genome, ViralCell Cycle CheckpointsCells, CulturedEnzyme ActivationFluorescent Antibody TechniqueGene AmplificationHuman papillomavirus 16Human papillomavirus 18HumansImmunoblottingImmunohistochemistryIn Situ Hybridization, FluorescenceKeratinocytesLife Cycle StagesMutagenesis, Site-DirectedOncogene Proteins, ViralE1 protein, Human papillomavirus 16oncogene protein E1, Human papillomavirus type 18oncogene protein E4, Human papillomavirus type 16oncogene protein E4, Human papillomavirus type 18Oncogene Proteins, Viral

Identifiers

PMID28306742
PMCPMC5371391
OpenAlexW2595495729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.